Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (2898)	10/28/2000 2:24:22 PM
From: StockDung	Respond to of 5582

That one went right off the TheTruthseeker Bogatier index.

To: DanZ who wrote (2898)	10/28/2000 2:32:05 PM
From: Mad2	Read Replies (2) \| Respond to of 5582

Dan, Cold-ease and ZICAM are very similar in that they both promise to reduce the duration of a cold. QGLY was a hot stock the first year its product came out and yes they actually made money.....but where is there stock price???? How did shareholders ultimatly benifit, the ones that hung on or averaged down???? GUMM 3-5 years ago was touting the speacility gum business, didn't make money and shifted to the deal with Gel Tech (Davidson and the other guy have made money, you can bet on that. Kehoe made money....exercise of warrants and sale of stock), now that that deal is petering out the speculation is on with regard to Swedish Match. Ultimately it comes back to the same question....how do GUMM shareholders benifit. You throw around these rosy senarios, in the meantime GUMM doesn't make any money and insiders sell stock. Dan I've been comparing GUMM to QGLY because looking at QGLY you can see where GUMM is headed and I haven't been wronge. Dan this stock isn't a investment, its speculation....which makes it a easy short. Mad2